179 related articles for article (PubMed ID: 24903091)
1. Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming.
Blair TA; Moore SF; Williams CM; Poole AW; Vanhaesebroeck B; Hers I
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1681-8. PubMed ID: 24903091
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase p110α negatively regulates thrombopoietin-mediated platelet activation and thrombus formation.
Blair TA; Moore SF; Walsh TG; Hutchinson JL; Durrant TN; Anderson KE; Poole AW; Hers I
Cell Signal; 2018 Oct; 50():111-120. PubMed ID: 29793021
[TBL] [Abstract][Full Text] [Related]
3. Enhanced platelet activity and thrombosis in a murine model of type I diabetes are partially insulin-like growth factor 1-dependent and phosphoinositide 3-kinase-dependent.
Stolla MC; Li D; Lu L; Woulfe DS
J Thromb Haemost; 2013 May; 11(5):919-29. PubMed ID: 23406214
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
Matheny RW; Lynch CM; Leandry LA
Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
[TBL] [Abstract][Full Text] [Related]
5. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
O'Brien KA; Gartner TK; Hay N; Du X
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751
[TBL] [Abstract][Full Text] [Related]
6. The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function.
Gushiken FC; Hyojeong H; Pradhan S; Langlois KW; Alrehani N; Cruz MA; Rumbaut RE; Vijayan KV
PLoS One; 2009 Dec; 4(12):e8304. PubMed ID: 20016849
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform.
Kim S; Garcia A; Jackson SP; Kunapuli SP
Blood; 2007 Dec; 110(13):4206-13. PubMed ID: 17827385
[TBL] [Abstract][Full Text] [Related]
8. Integrin αIIb-mediated PI3K/Akt activation in platelets.
Niu H; Chen X; Gruppo RA; Li D; Wang Y; Zhang L; Wang K; Chai W; Sun Y; Ding Z; Gartner TK; Liu J
PLoS One; 2012; 7(10):e47356. PubMed ID: 23082158
[TBL] [Abstract][Full Text] [Related]
9. Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function.
Moore SF; Smith NR; Blair TA; Durrant TN; Hers I
Sci Rep; 2019 Feb; 9(1):1468. PubMed ID: 30728366
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.
Moore SF; Hunter RW; Hers I
J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393
[TBL] [Abstract][Full Text] [Related]
11. Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition.
Leroy C; Ramos P; Cornille K; Bonenfant D; Fritsch C; Voshol H; Bentires-Alj M
Breast Cancer Res; 2016 Apr; 18(1):41. PubMed ID: 27048245
[TBL] [Abstract][Full Text] [Related]
12. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts.
Matheny RW; Adamo ML
Biochem Biophys Res Commun; 2009 Dec; 390(2):252-7. PubMed ID: 19799871
[TBL] [Abstract][Full Text] [Related]
13. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
Jia S; Liu Z; Zhang S; Liu P; Zhang L; Lee SH; Zhang J; Signoretti S; Loda M; Roberts TM; Zhao JJ
Nature; 2008 Aug; 454(7205):776-9. PubMed ID: 18594509
[TBL] [Abstract][Full Text] [Related]
14. PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.
Wang Q; Liu P; Spangle JM; Von T; Roberts TM; Lin NU; Krop IE; Winer EP; Zhao JJ
Oncogene; 2016 Jul; 35(27):3607-12. PubMed ID: 26500061
[TBL] [Abstract][Full Text] [Related]
15. Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER
Hosford SR; Dillon LM; Bouley SJ; Rosati R; Yang W; Chen VS; Demidenko E; Morra RP; Miller TW
Clin Cancer Res; 2017 Jun; 23(11):2795-2805. PubMed ID: 27903677
[No Abstract] [Full Text] [Related]
16. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway.
Hers I
Blood; 2007 Dec; 110(13):4243-52. PubMed ID: 17827393
[TBL] [Abstract][Full Text] [Related]
18. Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting PI3K/Akt pathway.
Hadas K; Randriamboavonjy V; Elgheznawy A; Mann A; Fleming I
PLoS One; 2013; 8(9):e74401. PubMed ID: 24058557
[TBL] [Abstract][Full Text] [Related]
19. PDGF- and insulin/IGF-1-specific distinct modes of class IA PI 3-kinase activation in normal rat retinas and RGC-5 retinal ganglion cells.
Biswas SK; Zhao Y; Nagalingam A; Gardner TW; Sandirasegarane L
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3687-98. PubMed ID: 18421086
[TBL] [Abstract][Full Text] [Related]
20. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]